Yen-Hung Lin, MD, PhD, FESC

Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan

Interests: amyolidosis; cardiology; heart failure; hypertension; primary aldosteronism; pulmonary hypertension; heart rhythm complexity
Yen-Wen Wu, MD, PhD

Division of Cardiology, Cardiovascular Medical Center, Far Eastern Memorial Hospital, New Taipei City, Taiwan; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Graduate Institute of Medicine, Yuan Ze University, Taoyuan, Taiwan

Interests: cardiology; heart failure; atherosclerosis; biomarkers; nuclear medicine; SPECT; PET; molecular imaging

Special Issues and Topics in IMR Press journals

Special Issue in Cardio-Oncology
Mei-Fang Cheng, MD

Department of Nuclear Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan

Interests: nuclear cardiology; nuclear oncology; positron emission tomography; molecular imaging; small animal PET imaging
Cheng-Hsuan Tsai, MD

Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan

Interests: heart failure; hypertension; primary aldosteronism; pulmonary hypertension; cardiomyopathy; intervention cardiology

Special Issue Information

Dear Colleagues,

Cardiac amyloidosis is characterized by the accumulation of misfolded transthyretin fibrils in the myocardium, resulting in heart failure and progressive, life-threatening diseases. Early diagnosis and a multidisciplinary approach are crucial for improving the long-term outcome for this condition. The two primary types of cardiac amyloidosis, ATTR and light chain, each require distinct diagnostic and management strategies. Although numerous novel pharmacological approaches have been developed for treating cardiac amyloidosis, their therapeutic efficacy is still being investigated. Furthermore, the optimal tools for disease monitoring and follow-up are areas of ongoing research.

This special issue entitled “Management of Cardiac Amyloidosis”, aims to highlight the diagnosis of cardiac amyloidosis and the multidisciplinary teamwork required for disease monitoring and medical management. We warmly invite you to contribute your ideas, valuable study results, or reviews for this special issue with the goal of stimulating further research in this field.

Prof. Yen-Hung Lin, Dr. Yen-Wen Wu, Dr. Mei-Fang Cheng and Dr. Cheng-Hsuan Tsai
Guest Editors

Keywords

cardiac amyloidosis

light chain cardiac amyloidosis

transthyretin amyloid cardiomyopathy

Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2200 USD. Submitted manuscripts should be well formatted in good English.

Rev. Cardiovasc. Med. Print ISSN 1530-6550 Electronic ISSN 2153-8174